SpringerLink
Log in

The 3rd Edition of Bethesda System for Reporting Thyroid Cytopathology: Highlights and Comments

  • Correspondence
  • Published:
Endocrine Pathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data Availability

No datasets were generated or analysed during the current study.

References

  1. Crippa S, Mazzucchelli L, Cibas ES, Ali SZ (2010) The Bethesda System for reporting thyroid fine-needle aspiration specimens. Am J Clin Pathol 134:343–344; author reply 345. https://doi.org/10.1309/AJCPXM9WIRQ8JZBJ

  2. Ali SZ, VanderLaan PA (2023) The Bethesda system for reporting thyroid cytopathology: definitions, criteria, and explanatory notes, Third edition. Springer, Cham

    Book  Google Scholar 

  3. Gan TRX, Nga ME, Lum JHY, Wong WM, Tan WB, Parameswaran R, Ngiam KY (2017) Thyroid cytology-nuclear versus architectural atypia within the “Atypia of undetermined significance/follicular lesion of undetermined significance” Bethesda category have significantly different rates of malignancy. Cancer Cytopathol 125:245–256. https://doi.org/10.1002/cncy.21823

    Article  PubMed  Google Scholar 

  4. Glass RE, Levy JJ, Motanagh SA, Vaickus LJ, Liu X (2021) Atypia of undetermined significance in thyroid cytology: nuclear atypia and architectural atypia are associated with different molecular alterations and risks of malignancy. Cancer Cytopathol 129:966–972. https://doi.org/10.1002/cncy.22495

    Article  CAS  PubMed  Google Scholar 

  5. Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, LiVolsi VA, Papott, Sobrinho Simões M, Tallini G, Mete O (2022) Overview of the 2022 WHO classification of thyroid neoplasms. Endocrine Pathology. https://doi.org/10.1007/s12022-022-09707-3

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden

    C. Christofer Juhlin

  2. Department of Pathology & Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

    Zubair W. Baloch

Authors
  1. C. Christofer Juhlin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zubair W. Baloch
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

CJ and ZB discussed the manuscript content. CJ wrote the first draft of manuscript text and prepared Fig. 1. ZB edited and provided feedback and both CJ and ZB finalized the manuscript. All authors have reviewed the final version and have approved it for submission.

Corresponding author

Correspondence to Zubair W. Baloch.

Ethics declarations

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Juhlin, C.C., Baloch, Z.W. The 3rd Edition of Bethesda System for Reporting Thyroid Cytopathology: Highlights and Comments. Endocr Pathol 35, 77–79 (2024). https://doi.org/10.1007/s12022-023-09795-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12022-023-09795-9

Keywords

Search

Navigation